Joshua LaBaer

Executive Director (FSC) & Professor
Biodesign Administration
Center Director
Biodesign CPD LL
Interim Center Director
Neurodegenerative Disease Research Center
Center Director
Biodesign CPD CM
Center Director
Personalized Diagnostics
Center Director
Biodesign CPD RC
Executive Director
Biodesign Administration
Faculty Member
Biodesign Administration
Faculty Member
Personalized Diagnostics

Location: TEMPE

Contact Information
(480) 965-2805


  • M.D. University of California School of Medicine 1990
  • Ph.D. Biochemistry and Biophysics, University of California School of Medicine 1989

Research Interests

  • Finding drug and vaccine targets for biodefense pathogens
  • Disease biomarker discovery
  • Estrogen resistance in breast cancer
  • Protein microarray technology and protein interaction mapping
  • DNA-damage checkpoint regulation


Visit the LaBaer Site
Biodesign Center for Personalized Diagnostics

Joshua LaBaer is one of the nation’s foremost investigators in the rapidly expanding field of personalized diagnostics. His efforts focus on the discovery and validation of biomarkers — unique molecular fingerprints of disease — which can provide early warning for those at risk of major illnesses, including cancer and diabetes. Formerly founder and director of the Harvard Institute of Proteomics, LaBaer was recruited to ASU’s Biodesign Institute as the first Piper Chair in Personalized Medicine in 2009.  The Virginia G. Piper Center for Personalized Diagnostics (VGPCPD) has a highly multidisciplinary staff of molecular biologists, cell biologists, biochemists, software engineers, database specialists, bioinformaticists, biostatisticians, and automation engineers.  VGPCPD applies open reading frame clones to the high throughput (HT) study of protein function.  In addition, his group invented a novel protein microarray technology, Nucleic Acid Programmable Protein Array, which has been used widely for biomedical research, including the recent discovery of a panel of 28 autoantibody biomarkers that may aid the early diagnosis of breast cancer. LaBaer earned his medical degree and a doctorate in biochemistry and biophysics, from the University of California, San Francisco.  He completed his medical residency at the Brigham and Women’s Hospital and a clinical fellowship in oncology at the Dana-Farber Cancer Institute, both in Boston. He has contributed more than 140 original research publications, reviews and chapters. LaBaer is an associate editor of the Journal of Proteome Research, a recent member of the National Cancer Institute’s Board of Scientific Advisors, Chair of the Early Detection Research Network Steering Committee and recent president of the U.S. Human Proteome Organization. 

Awards and Honors:

  • 1978 Edward Frank Kraft Prize for Outstanding Academic Achievement, University of California
  • 1977-1981 Regents Scholar, University of California
  • 1981 Phi Beta Kappa
  • 1981 Citation for Outstanding Student Research, UC Berkeley
  • 1981 University Medal for Most Distinguished Graduating Senior, UC Berkeley
  • 1981 Graduation with Highest Honors, UC Berkeley
  • 1985 Deanâs Prize for Student Research
  • 1986-1987 Chancellorâs Fellowship
  • 1989 Alpha Omega Alpha
  • 2001-04 Arthur and Rochelle Belfer Foundation Awardee, Breast Cancer Research Foundation
  • 2005- Breast Cancer Research Foundation
  • 2007 Kavli Frontiers of Science Symposium Recipient
  • 2009 The Otto Herz Memorial Lectureship in Cancer Research
  • 2009 The Virginia G. Piper Chair of Personalized Medicine
  • 2011 Health Care Hero [researcher/innovator]; Phoenix Business Journal